$
0.04
09:41 AM EST
New Key Statistics Module, Z-Score and F-Score
OTCPK:OTLC Key Ratios
Market Cap $ M | 15.99 |
Enterprise Value $ M | 28.15 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.33 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.02 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -205.90 |
EV-to-EBIT | -3.93 |
EV-to-EBITDA | -3.93 |
PEG | -- |
Shares Outstanding M | 399.68 |
Net Margin (%) | -11,290.00 |
Operating Margin % | -860.00 |
Pre-tax Margin (%) | -11,722.86 |
Quick Ratio | 0.02 |
Current Ratio | 0.02 |
ROA % (ttm) | -24.35 |
ROE % (ttm) | -52.58 |
ROIC % (ttm) | -1.29 |
Dividend Yield % | -- |
Altman Z-Score | -2.48 |
Piotroski F-Score | 3.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | N |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
OTLC Number of Guru Trades
OTLC Volume of Guru Trades
Gurus Latest Trades with OTCPK:OTLC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:OTLC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Oncotelic Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:OTLC
Total 0- 1